AGXT and myeloid sarcoma: Because our study indicates an elevation of ceramide via SPT activation leading to ceramide/sphingosine accumulation in MS [2], we propose that a therapy to block the SPT1 gene using miRNA technology will prevent the ceramide generation and this may be considered as an alternate therapeutic approach.